STERIS plc (STE) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | |
| Borrowing debt due after one year | 1.65B USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Excluding Current Maturities |
| Total assets | 10.74B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $1.65B | (m) | (m) | $10.74B | (m) |
| 2026-03-31 | (m) | (m) | (m) | $1.81B | (m) | (m) | $10.74B | (m) |
| 2025-12-31 | (m) | (m) | (m) | $1.90B | (m) | (m) | $10.59B | (m) |
| 2025-09-30 | (m) | (m) | (m) | $1.90B | (m) | (m) | $10.41B | (m) |
| 2025-06-30 | (m) | (m) | (m) | $1.90B | (m) | (m) | $10.40B | (m) |
| 2025-03-31 | (m) | (m) | (m) | $1.92B | (m) | (m) | $10.15B | (m) |
| 2024-12-31 | (m) | (m) | (m) | $2.04B | (m) | (m) | $10.01B | (m) |
| 2024-09-30 | (m) | (m) | (m) | $2.16B | (m) | (m) | $10.24B | (m) |
| 2024-06-30 | (m) | (m) | (m) | $2.24B | (m) | (m) | $10.11B | (m) |
| 2024-03-31 | (m) | (m) | (m) | $3.12B | (m) | (m) | $11.06B | (m) |
| 2023-12-31 | (m) | (m) | (m) | $3.23B | (m) | (m) | $11.44B | (m) |
| 2023-09-30 | (m) | (m) | (m) | $3.37B | (m) | (m) | $11.28B | (m) |
| 2023-06-30 | (m) | (m) | (m) | $2.86B | (m) | (m) | $10.78B | (m) |
| 2023-03-31 | (m) | (m) | (m) | $3.02B | (m) | (m) | $10.82B | (m) |
| 2022-12-31 | (m) | (m) | (m) | $3.00B | (m) | (m) | $10.80B | (m) |
| 2022-09-30 | (m) | (m) | (m) | $2.87B | (m) | (m) | $10.49B | (m) |
| 2022-06-30 | (m) | (m) | (m) | $2.85B | (m) | (m) | $11.19B | (m) |
| 2022-03-31 | (m) | (m) | (m) | $2.95B | (m) | (m) | $11.42B | (m) |
| 2021-12-31 | (m) | (m) | (m) | $3.18B | (m) | (m) | $11.69B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $3.42B | (m) | (m) | $11.75B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $3.26B | (m) | (m) | $12.10B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $1.65B | (m) | (m) | $6.57B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $1.71B | (m) | (m) | $6.58B | (m) |
| 2020-09-30 | (m) | (m) | (m) | $1.02B | (m) | (m) | $5.49B | (m) |
| 2020-06-30 | (m) | (m) | (m) | $1.02B | (m) | (m) | $5.36B | (m) |
| 2020-03-31 | (m) | (m) | (m) | $1.15B | (m) | (m) | $5.43B | (m) |
| 2019-12-31 | (m) | (m) | (m) | $1.14B | (m) | (m) | $5.34B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $1.19B | (m) | (m) | $5.19B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $1.21B | (m) | (m) | $5.23B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $1.18B | (m) | (m) | $5.07B | (m) |
| 2018-03-31 | (m) | (m) | (m) | $1.32B | (m) | (m) | $5.20B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |